# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Christopher Reeve (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML024-SYN
- Date: 2026-04-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Teresa Galloway, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week review, seen the same day by spinal cord injury medicine, with a bone density scan and kidney and bladder ultrasound. **S**

## History of present illness

Mr. Reeve returns two weeks after his first visit and is seen by Dr. Kovac of physical medicine and rehabilitation on the same day. He uses the diaphragm pacer for two hours twice a day, as the pacing team advised, and the ventilator the rest of the time; he tires toward the end of each session but his saturation stays at 96 to 97%. His secretions are thin and his nurses suction a few times a day and use the cough-assist device each morning. His skin has stayed intact. His bowel program has worked each morning, and his catheter drains well. He has had no pounding headaches, flushing or sweating above the injury. His neck and shoulders ache after long days in the chair. He has continued stimulated cycling three times a week. All of his regular nurses have now been trained in the autonomic dysreflexia plan, and he carries the wallet card. He had his bone density scan and kidney and bladder ultrasound this morning. **S**

| Element | Detail |
|---|---|
| Breathing | Pacer two hours twice a day; ventilator otherwise; saturation 96 to 97% on the pacer |
| Autonomic dysreflexia | No episodes; plan and wallet card in place; nurses trained |
| Skin | Intact |
| Bladder and bowel | Catheter draining well; bowel program effective |
| Pain | Neck and shoulder aching after long days |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Respiratory | Negative | Secretions thin and clear; no fever |
| Cardiovascular | Negative | No pounding headaches, flushing or sweating above the injury; no leg swelling |
| Genitourinary | Negative | Urine clear; no blockages |
| Gastrointestinal | Negative | Bowel program effective; no accidents |
| Musculoskeletal | Positive | Neck and shoulder aching after long days in the chair |
| Integumentary | Negative | No redness over pressure points |

6 systems reviewed. **S**

## Current medications

- Sennosides 8.6 mg oral tablet, two tablets at bedtime **S**
- Nitroglycerin 2% ointment, one inch to the skin of the chest only if systolic blood pressure stays at 150 mmHg or higher after the first steps of the autonomic dysreflexia plan; wipe off when pressure falls **S**
- Acetaminophen 500 mg oral tablet, two tablets up to three times a day as needed for neck and shoulder aching **S**
- Cholecalciferol (vitamin D3) 2000 units (50 mcg) oral capsule, one capsule daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 102/62 mmHg; pulse 60 bpm; respirations 12/min; temperature 36.4 °C; oxygen saturation 97% on his home ventilator settings via tracheostomy, no supplemental oxygen; weight 82.2 kg; BMI 22.1 kg/m². All vital signs are synthetic.

Total hip T-score: -1.6 (low); Braden scale: 11. All results are synthetic.

## Change since baseline

- Braden scale: 11 at baseline, 11 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; seated in his power wheelchair; blood pressure 102/62, pulse 60 |
| Respiratory | On the ventilator during the visit; clear breath sounds; tracheostomy stoma clean; pacer lead exit sites clean and dry |
| Skin | Intact over the sacrum, ischia, trochanters, heels, elbows and occiput; Braden score 11 |
| Musculoskeletal | Tender upper trapezius muscles on both sides; neck range of motion full |
| Neurological | Sensation present over much of the body; some voluntary finger and wrist movement; mild spasticity in the legs (modified Ashworth 1) |
| Extremities | No leg swelling |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Ventilator dependence with diaphragm pacing** (Z99.11). Tolerating two hours twice a day on the pacer with stable saturation. Dr. Kovac advises stepping up session length by about 15 minutes each week as tolerated, stopping early for fatigue, breathlessness or saturation below 94%. **S**
   - Weekly step-up of pacer time as tolerated, logged by his nurses.
   - Continue daily cough assist and suctioning as needed.
2. **Chronic incomplete C2 tetraplegia** (G82.52). No autonomic dysreflexia; plan in place. Bone density scan: total hip T-score -1.6, low bone mass, with low distal femur and proximal tibia densities, as expected below the injury; no fragility fracture. Calcium 9.0 mg/dL and PTH 52 pg/mL normal, but 25-hydroxyvitamin D 22 ng/mL is insufficient. Neck and shoulder aching is muscular, from head support and long sitting. **S**
   - Start vitamin D3 2000 units daily; recheck in about eight weeks.
   - No bone-protective medicine now; continue stimulated cycling; careful transfers and ranging.
   - Repeat DXA in two years.
   - Seating pressure mapping and cushion and head-support review with the seating clinic.
   - Acetaminophen as needed; heat and stretching for the neck and shoulders.
3. **Neurogenic bladder with an indwelling catheter** (N31.9). Kidney and bladder ultrasound today: no hydronephrosis or stones; mild bladder wall thickening with the catheter in place. Cystatin C 0.92 mg/L, eGFR 90 at intake. **S**
   - Continue catheter care with monthly changes.
   - Ultrasound again in one year.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Autonomic dysreflexia: episodes, baseline blood pressure, written plan, and nurse training | Every visit | Completed today | No episodes; baseline blood pressure about 102/62 recorded on the plan; all regular nurses trained; wallet card with him |
| Survey | Skin check and Braden scale | Every visit | Completed today | Skin intact at all pressure points; Braden 11, high risk |
| Self-management | Seating, cushion, and pressure mapping | At least yearly and after any change in equipment, weight or skin | Ordered | Pressure mapping and cushion and head-support review requested from the seating clinic today |
| Self-management | Catheter care and urinary symptoms | Every visit | Completed today | Draining well; monthly change due next week; no symptoms of infection |
| Laboratory | Kidney function (cystatin C; creatinine unreliable with low muscle mass) | At baseline, then every 6 to 12 months | Up to date | Cystatin C 0.92 mg/L, eGFR 90 at intake; creatinine 0.48 mg/dL reflects low muscle mass |
| Imaging | Kidney and bladder ultrasound | Yearly | Completed today | No hydronephrosis or stones; mild bladder wall thickening |
| Self-management | Bowel program | Every visit | Completed today | Effective each morning with suppository and digital stimulation; no accidents |
| Examination | Pacer conditioning, oxygen saturation, and secretion clearance | Every visit | Completed today | Pacer two hours twice a day with saturation 96 to 97%; weekly step-up advised |
| Self-management | Backup ventilator, suction, cough-assist device, and power plan | Every visit, with monthly checks by his nurses | Completed today | Backup ventilator, suction and cough assist checked; generator tested; power company and emergency services registration confirmed |
| Imaging | Bone density (DXA of the hip and knee regions) | Baseline, then every 2 years | Completed today | Total hip T-score -1.6; low distal femur and proximal tibia densities |
| Laboratory | 25-hydroxyvitamin D | At baseline, 8 to 12 weeks after repletion, then yearly | Up to date | 22 ng/mL at intake, insufficient; vitamin D3 started today |
| Laboratory | Lipids, A1c, and blood pressure | Yearly | Up to date | LDL 104, HDL 34, triglycerides 170 mg/dL; A1c 5.5% at intake |
| Survey | Depression screen (PHQ-9) | At intake, then every 6 to 12 months and with any change | Up to date | PHQ-9 3 at intake |
| Examination | Pain score and pain plan | Every visit | Completed today | Muscular neck and shoulder aching; heat, stretching and head-support review |
| Examination | Spasticity and range of motion | Every visit | Completed today | Modified Ashworth 1 in the legs; daily ranging; no medicine needed |
| Examination | Venous thromboembolism: leg swelling | Every visit; prophylaxis only during acute illness, surgery or immobilization | Completed today | No leg swelling; no prophylaxis in the chronic phase |
| Referral | Spinal cord injury medicine review | At intake, then at least yearly | Completed today | Seen by Dr. Kovac today |

## Goal progress

- Lengthen time on the diaphragm pacer to at least three hours twice a day by six months, with stable oxygen saturation. In progress; target 2026-10-26. **S**
- No pressure injury: skin intact at every check through six months. In progress; target 2026-10-26. **S**
- Written autonomic dysreflexia plan held by him and every nurse, with all nurses trained, by the two-week visit. Outcome by 2026-04-27: Plan and wallet card in place; all regular nurses trained. **S**
- 25-hydroxyvitamin D at least 30 ng/mL within three months. In progress; target 2026-06-22. **S**
- No unplanned hospital admission through six months. In progress; target 2026-10-26. **S**

## Medication changes

- Started: Cholecalciferol (vitamin D3) 2000 units (50 mcg) oral capsule, one capsule daily **S**

## Guideline basis

- Evaluation and Management of Autonomic Dysreflexia and Other Autonomic Dysfunctions: Preventing the Highs and Lows (Consortium for Spinal Cord Medicine) (2021), Paralyzed Veterans of America (Journal of Spinal Cord Medicine)
- Pressure Ulcer Prevention and Treatment Following Spinal Cord Injury: A Clinical Practice Guideline for Health-Care Providers, Second Edition (Consortium for Spinal Cord Medicine) (2014), Paralyzed Veterans of America
- Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers (Consortium for Spinal Cord Medicine) (2006), Paralyzed Veterans of America (Journal of Spinal Cord Medicine)
- The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up (2021), American Urological Association and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (Journal of Urology)
- Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers (Consortium for Spinal Cord Medicine) (2021), Paralyzed Veterans of America (Topics in Spinal Cord Injury Rehabilitation)
- Respiratory management following spinal cord injury: a clinical practice guideline for health-care professionals (Consortium for Spinal Cord Medicine) (2005), Paralyzed Veterans of America (Journal of Spinal Cord Medicine)
- Bone Health and Osteoporosis Management in Individuals with Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers (Consortium for Spinal Cord Medicine) (2022), Paralyzed Veterans of America
- Identification and Management of Cardiometabolic Risk after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers (Consortium for Spinal Cord Medicine) (2018), Paralyzed Veterans of America (Topics in Spinal Cord Injury Rehabilitation)
- Management of Mental Health Disorders, Substance Use Disorders, and Suicide in Adults with Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers (Consortium for Spinal Cord Medicine) (2021), Paralyzed Veterans of America (Topics in Spinal Cord Injury Rehabilitation)
- Prevention of Venous Thromboembolism in Individuals with Spinal Cord Injury: Clinical Practice Guidelines for Health Care Providers, 3rd ed. (Consortium for Spinal Cord Medicine) (2016), Paralyzed Veterans of America (Topics in Spinal Cord Injury Rehabilitation)
- Evaluation and Management of Pain After Spinal Cord Injury (Consortium for Spinal Cord Medicine) (2026), Paralyzed Veterans of America
- CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026), Aether Forge

## Follow-up

- Review in eight weeks with vitamin D, a skin check and the pacer log. Seating clinic appointment to be booked. Use the autonomic dysreflexia plan and call for fever, cloudy urine with symptoms, or any skin redness that does not fade within 30 minutes. **S**
- Next scheduled visit 2026-06-22: ten-week review: pacer conditioning, skin, vitamin D, and seating. **S**
